Skip to main content

Table 1 Comparison of patient baseline characteristics in the IGRT and non-IGRT groups

From: Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy

T stage IGRT Non-IGRT P value
1 78(30%) 9(35%)  
2 137(52%) 13(50%)  
3a 40(15%) 3(12%)  
3b 6(2%) 0(0%)  
4 0(0%) 1(4%)  
Not available 4(1%) 0  
Total 265 26 0.8987
Gleason    
≤ 6 61(23%) 9(35%)  
7 147(55%) 11(42%)  
8 31(12%) 2(8%)  
9 21(8%) 3(12%)  
10 1(0.4%) 1(4%)  
Not available 4(1%) 0  
Total 265 26 0.5782
PSA (ng/ml)    
< 4 13(5%) 0(0%)  
4-10 126(48%) 14(54%)  
10.1-20 85(32%) 8(31%)  
> 20 37(14%) 4(15%)  
Not available 4(1%) 0  
Total 265 26 0.661
Prior TURP 56 (21%) 6 (23%) 0.8043
Neoadjuvant LHRH agonist 131 (50%) 11 (42%) 0.5407
Diabetes 61 (23%) 4 (15%) 0.4656
Hypertension 145 (55%) 13 (50%) 0.6827